{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T18:23:48Z","timestamp":1751048628552},"reference-count":6,"publisher":"American Medical Association (AMA)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Ophthalmol"],"published-print":{"date-parts":[[2024,3,1]]},"DOI":"10.1001\/jamaophthalmol.2023.6775","type":"journal-article","created":{"date-parts":[[2024,2,15]],"date-time":"2024-02-15T16:01:25Z","timestamp":1708012885000},"page":"272","source":"Crossref","is-referenced-by-count":3,"title":["Is Recommending 0.01% Atropine for Myopia Control Clinically Meaningful?\u2014Reply"],"prefix":"10.1001","volume":"142","author":[{"given":"Karla","family":"Zadnik","sequence":"first","affiliation":[{"name":"The Ohio State University College of Optometry, Columbus"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian","family":"Flitcroft","sequence":"additional","affiliation":[{"name":"Centre for Eye Research, Dublin, Ireland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Houman D.","family":"Hemmati","sequence":"additional","affiliation":[{"name":"Vyluma Inc, Bridgewater, New Jersey"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10","reference":[{"issue":"10","key":"elr230014r1","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1001\/jamaophthalmol.2023.2097","article-title":"Efficacy and safety of 0.01% and 0.02% atropine for the treatment of pediatric myopia progression over 3 years: a randomized clinical trial.","volume":"141","author":"Zadnik","year":"2023","journal-title":"JAMA Ophthalmol"},{"issue":"4","key":"elr230014r2","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1167\/iovs.02-0816","article-title":"A randomized clinical trial of progressive addition lenses versus single vision lenses on the progression of myopia in children.","volume":"44","author":"Gwiazda","year":"2003","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"13","key":"elr230014r3","doi-asserted-by":"publisher","first-page":"7871","DOI":"10.1167\/iovs.13-12403","article-title":"Myopia stabilization and associated factors among participants in the Correction of Myopia Evaluation Trial (COMET).","volume":"54","author":"COMET Group","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"12","key":"elr230014r4","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1001\/jamaophthalmol.2016.4009","article-title":"Association of axial length with risk of uncorrectable visual Impairment for Europeans with myopia.","volume":"134","author":"Tideman","year":"2016","journal-title":"JAMA Ophthalmol"},{"issue":"1","key":"elr230014r5","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.ophtha.2018.05.029","article-title":"Low-Concentration Atropine for Myopia Progression (LAMP) study: a randomized, double-blinded placebo-controlled trial of 0.05%, 0.025% and 0.01% atropine eye drops in myopia control.","volume":"126","author":"Yam","year":"2019","journal-title":"Ophthalmology"},{"issue":"9","key":"elr230014r6","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1111\/ceo.v50.9","article-title":"Low-concentration atropine eyedrops for myopia control in a multi-racial cohort of Australian children: a randomised clinical trial.","volume":"50","author":"Lee","year":"2022","journal-title":"Clin Exp Ophthalmol"}],"container-title":["JAMA Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaophthalmology\/articlepdf\/2814946\/jamaophthalmology_zadnik_2024_lr_230014_1710970263.5629.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,21]],"date-time":"2024-03-21T15:02:42Z","timestamp":1711033362000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaophthalmology\/fullarticle\/2814946"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,1]]},"references-count":6,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaophthalmol.2023.6775","relation":{},"ISSN":["2168-6165"],"issn-type":[{"value":"2168-6165","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3,1]]}}}